The CCCA has completed its analysis of the ivermectin arm of the TOGETHER trial (published in the New England Journal of Medicine (NEJM) on March 30th 2022; Effect of Early Treatment with Ivermectin among Patients with Covid-19). This high-profile trial sought to evaluate the potential of repurposing multiple previously established medications for the management of COVID-19. We have identified numerous issues with the study protocol and analysis which raise deep concerns about the publicized conclusions of the trial’s ivermectin arm.
Recommended citation: Halgas, O. (2022) Analysis of the TOGETHER Trial’s Ivermectin Arm Results. Canadian Covid Care Alliance. April 28, 2022. https://canadiancovidcarealliance.org/media-resources/analysis-together-ivermectin-trial/
